Cannabis investors looking to buy low need to check out the biggest cannabis stock IPO of 2021.
An early industry leader valued at $1.7 billion just began trading on the Canadian Stock Exchange. And while this company is delivering crazy sales growth, shares have hardly moved since going public, making this a bargain opportunity in the cannabis sector.
Continue reading “$1.7 Billion Cannabis Stock IPO: Buy or Pass?”
For the last few years, the cannabis sector has experienced extended periods of strength followed by large pullbacks that lasted on average three to six months. During this period, buying cannabis stocks on a pullback has been a highly effective strategy.
Today, investors want to know if this a good time to buy cannabis stocks…
The short answer is yes.
I see five powerful catalysts that tell me this is a great time to buy cannabis stocks. Continue reading “5 Reasons It’s Time to Buy Cannabis Stocks”
Mergers and acquisitions (M&A) continue to heat up in the cannabis sector. This is a trend that investors need to know about because it’s creating an opportunity to pick up a quick gain.
The latest evidence?
Harvest Health and Recreation (CSE: HARV, OTC: HRVSF), one of the largest cannabis companies in the U.S., jumped 35% in five days after announcing it was being bought by Trulieve Cannabis (CSE: TRUL, OTC: TCNNF), also a cannabis giant in the U.S.
Shares of Harvest responded with a big rally. Shares jumped 35% in five days. Continue reading “Columbia Care (CSE: CHWF, OTC: CHWBF): The Next 35% Gain in 2 Days?”
The cannabis sector has a new king – an $8 billion, international juggernaut with more than a half-billion in revenue in the last 12 months.
I am going to reveal three key reasons why I call this early industry leader a long-term buy and hold. Continue reading “$8 Billion Weed Merger – Buy or Sell?”
Psychedelic stocks are quickly emerging as a red-hot sector.
Need evidence?
Take a look at Mind Medicine (NASDAQ: MNMD), a promising young biotech headquartered in New York, New York, that specializes in developing psychedelic drug therapies.
Shares were just uplisted from over-the-counter (OTC) markets to the NASDAQ stock exchange, and this stock is now up more than 1,000% in the last nine months. Continue reading “Psychedelic Stock IPO the Next 1,000% Gain?”
When the Democrats swept the U.S. elections in November, cannabis investors were excited over the potential for major cannabis reform. Today, 90 days into the Biden administration, we have a much better idea of what to expect.
While it looks like reforms may fall short of the holy grail of ‘federal legalization,’ I see a high probability of game-changing cannabis reform in 2021. Continue reading “Is This a Good Time to Buy Cannabis Stocks?”
It’s one of Wall Street’s best-kept secrets – a studied market anomaly that helps investors ride a move after a company reports an earnings surprise. And right now looks like a great time to apply this strategy to the cannabis sector after two of the most exciting cannabis stocks just crushed fourth-quarter expectations.
I’m talking about post-earnings announcement drift (PEAD) – the tendency for stocks that beat earnings expectations to deliver outsized returns in the following weeks and months. Continue reading “2 Earnings-Beating Cannabis Stocks Ready to Move”
In 2014, Colorado became the first U.S. state to legalize recreational cannabis. Since then, sales have boomed, hitting a new all-time high of $2 billion in 2020.
Today I will reveal how to invest in this powerful trend with a secret cannabis stock that is one of the most undervalued in the industry. Continue reading “The Only Pure Play on Colorado’s $2 Billion Cannabis Market”
Joe Biden has been sworn in as the 46th President of the United States. There are few groups more excited than cannabis investors. The Joe Biden presidency is likely to fuel even better growth in the U.S. cannabis industry.
While I expect many cannabis stocks to benefit, I believe that one is in the best position to benefit from a cannabis-friendly administration.
Biden isn’t a huge cannabis advocate himself, but he does support decriminalization, and more importantly, he will be surrounded by pro-cannabis allies. Continue reading “#1 Weed Stock for Joe Biden’s First 100 Days”
When a stock jumps 124% in three weeks, it’s time to pay attention.
That’s what just happened to Liberty Health Sciences (CSE: LHS, OTC: LHSIF), one of the biggest players in Florida’s high-growth medical cannabis market, after the company announced it was being bought by a competitor. Continue reading “The Next Big Cannabis Buyout Target”